Showing results (61-70 of 124) with videos related to
Sort By:
Pageof 13
NMC Case Report Journal|May 9, 2025
A Rare Case of Adult-onset Gangliocytoma in the Parietal Lobe: Case Report and Surveillance, Epidemiology, and End Results Registry Data AnalysisRyosuke Ikemachi, Yusuke Tomita, Yoshihiro Otani, et al.Dalton Transactions (Cambridge, England : 2003)|December 16, 2024
Electronic structures of blue copper centers of amicyanin and azurin in the solution stateYudai Izumi, Ralph Ugalino, Jun Miyawaki, et al.Japanese Journal of Infectious Diseases|May 1, 2022
Nafamostat Mesylate Monotherapy in Patients with Moderate COVID-19: a Single-Center, Retrospective StudyTomomi Soma, Kentaro Fujii, Ayumi Yoshifuji, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 5, 2022
Special AT-Rich Sequence-Binding Protein 1 Supports Survival and Maturation of Naive B Cells Stimulated by B Cell ReceptorsTakayuki Ozawa, Kentaro Fujii, Takao Sudo, et al.Future Oncology (London, England)|January 25, 2020
Study protocol of a Phase I/IIa clinical trial of Ad-SGE-REIC for treatment of recurrent malignant gliomaKazuhiko Kurozumi, Kentaro Fujii, Yosuke Shimazu, et al.NMC Case Report Journal|October 14, 2022
A Case of Relapsed Primary Central Nervous System Lymphoma Treated with CD19-directed Chimeric Antigen Receptor T Cell TherapyRyo Mizuta, Yoshihiro Otani, Kentaro Fujii, et al.Physical Chemistry Chemical Physics : PCCP|November 21, 2015
Investigation of the fragmentation of core-ionised deoxyribose: a study as a function of the tautomeric formMarie-Anne Hervé du Penhoat, Krishna Kamol Ghose, Marie-Pierre Gaigeot, et al.Brain Tumor Pathology|July 24, 2015
Evaluation of extracellular matrix protein CCN1 as a prognostic factor for glioblastomaJoji Ishida, Kazuhiko Kurozumi, Tomotsugu Ichikawa, et al.Clinical and Experimental Nephrology|February 8, 2022
Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patientsMasataro Toda, Ayumi Yoshifuji, Kan Kikuchi, et al.Vascular and Endovascular Surgery|December 12, 2022
Ultra-Low-Dose Contrast Using Transluminal Renal Angioplasty: The ULTRA StudyMegumi Kawano, Kenji Suzuki, Naoki Fujimura, et al.Pageof 13